Plasma Expander Market, By Type (Albumin, Dextran, Hydroxyethyl Starch, Gelatin, and Others), By Product Type (Colloids and Synthetic Expanders), By Application (Trauma and Surgical Procedures, Burn Management, Hypovolemia, Sports Medicine, and Others), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Published In : Nov 2023

Code : CMI5939

Pages :150

Formats :

Excel and PDF

Industry : Pharmaceutical

Plasma Expander MarketSize and Trends

Global plasma expander market size was valued at US$ 6.96 Bn in 2023 and is projected to reach US$ 15.9 Bn by 2030, by exhibiting a compounded annual growth rate (CAGR) of 12.5% from 2023 to 2030.

The market growth of the global plasma expander market is driven by the increasing prevalence of chronic diseases, rising number of surgeries, and growing demand for blood plasma-derived products. The increasing government funding for public hospitals and the rising complexity of surgeries are also expected to drive the market growth of the global plasma expander market.

Global Plasma Expander Market Trends

Increasing adoption of synthetic plasma expanders: Synthetic plasma expanders, such as hydroxyethyl starch (HES) and gelatin-based expanders have gained popularity due to their longer shelf life, consistent supply, and reduced risk of transmitting infectious diseases as compared to human plasma-based expanders. The market is witnessing a shift towards synthetic plasma expanders, which is driven by the need for safe and readily available alternatives. For instance, in 2020, a survey of 100 hospitals was conducted by the American Hospital Association, in U.S. revealed that, 96% of the hospitals primarily stock and use synthetic plasma expanders for resuscitation and emergency care. The reliance on blood plasma-derived products decreased from an average of 35% of total plasma expander usage in 2015 to just 8% in 2020. In 2022, according to a report published by the European Monitoring Centre for Drugs and Drug Addiction, a similar trend was observed among hospitals in the European Union that showed the massive shift towards synthetic options which provided a more reliable and secure choice.
Preference for colloidal plasma expanders: Colloidal plasma expanders, including albumin and starch-based expanders, are increasingly preferred over crystalloids in certain clinical scenarios. Colloidal expanders provide prolonged intravascular expansion due to their oncotic properties, thus making them suitable for cases of severe hypovolemia and in patients with low oncotic pressure.
Focus on safety and adverse event profiles: The safety profile of plasma expanders has gained significant attention in recent years. Adverse events which are associated with certain plasma expanders, such as renal dysfunction and coagulation disorders, prompted healthcare professionals to reassess their usage. Manufacturers are investing in research and development to develop safer plasma expanders with minimal side effects.